These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 7672707

  • 21. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
    Kushner DM, Webster KD, Belinson JL, Rybicki LA, Kennedy AW, Markman M.
    Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
    [Abstract] [Full Text] [Related]

  • 22. A pilot study of cisplatin, ifosfamide and mesna in the treatment of malignant mixed mesodermal tumors of the ovary.
    Crotzer DR, Wolf JK, Gano JB, Gershenson DM, Levenback C.
    Gynecol Oncol; 2007 May; 105(2):399-403. PubMed ID: 17292457
    [Abstract] [Full Text] [Related]

  • 23. Ifosfamide combination regimens for soft-tissue sarcoma.
    Stuart-Harris R, Dalley D, Bell DR, Levi J, Simes RJ, Wiltshaw E.
    Cancer Chemother Pharmacol; 1993 May; 31 Suppl 2():S185-8. PubMed ID: 8453695
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Mesna, Doxorubicin, Ifosfamide and Dacarbazine (MAID) Combination Chemotherapy for Retroperitoneal Sarcoma: A Single-center Experience.
    Ishiyama Y, Inakawa T, Yoshino M, Nishimura K, Horiuchi T, Ishihara H, Toki D, Kondo T.
    Anticancer Res; 2024 Jul; 44(7):3213-3220. PubMed ID: 38925814
    [Abstract] [Full Text] [Related]

  • 30. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.
    Barişta I, Tekuzman G, Yalçin S, Güllü I, Güler N, Ozişik Y, Kars A, Celik I, Türker A, Altundağ K, Zengin N, Uner A, Baltali E, Firat D.
    J Surg Oncol; 2000 Jan; 73(1):12-6. PubMed ID: 10649272
    [Abstract] [Full Text] [Related]

  • 31. Complete response of carcinosarcoma of the ovary to therapy with doxorubicin, ifosfamide, and dacarbazine.
    Simon SR, Wang SE, Uhl M, Shackney S.
    Gynecol Oncol; 1991 May; 41(2):161-6. PubMed ID: 2050307
    [Abstract] [Full Text] [Related]

  • 32. [Soft tissue sarcoma: postoperative chemotherapy].
    Goto T, Kosaku H, Kobayashi H, Hozumi T, Kondo T.
    Gan To Kagaku Ryoho; 2004 Sep; 31(9):1324-30. PubMed ID: 15446551
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PC, Blay JY, European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    J Clin Oncol; 2007 Jul 20; 25(21):3144-50. PubMed ID: 17634494
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
    Schütte J, Kellner R, Seeber S.
    Cancer Chemother Pharmacol; 1993 Jul 20; 31 Suppl 2():S194-8. PubMed ID: 8453697
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A high proliferation rate measured by cyclin A predicts a favourable chemotherapy response in soft tissue sarcoma patients.
    Huuhtanen RL, Wiklund TA, Blomqvist CP, Böhling TO, Virolainen MJ, Tribukait B, Andersson LC.
    Br J Cancer; 1999 Nov 20; 81(6):1017-21. PubMed ID: 10576659
    [Abstract] [Full Text] [Related]

  • 40. Excellent progression-free survival with liposomal doxorubicin for a patient with recurrent ovarian malignant mixed müllerian tumor: case report and literature review.
    Hsieh CL, Chang TC, Lai CH, Jung SM, Chou HH.
    Gynecol Oncol; 2004 Sep 20; 94(3):854-7. PubMed ID: 15350389
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.